论文部分内容阅读
1996年10月至2002年7月,我们对30例甲亢患者作了Holter监测。报告如下。 临床资料:本组男7例,女23例;年龄18～67(36.4±7.9)岁。均有高代谢症状,符合甲亢的实验室诊断标准。均未服用抗心律失常药物,无慢性咳嗽、高血压及其他心脏病病史。 方法:采用美国产DelMar263Holter分析系统,确诊甲亢后于治疗前记录Holter,经过3个月以上的正规治疗病情稳定后复查。 结果:①24小时心率变化:本组治疗后24小时平均心率较治疗前减少18次/min。②心律失常检出情况:1例持续性房颤、2例阵发性房颤患者治疗后转为窦性节律,13例早搏
From October 1996 to July 2002, we conducted Holter monitoring of 30 patients with hyperthyroidism. The report is as follows. Clinical data: The group of 7 males and 23 females; aged 18 to 67 (36.4 ± 7.9) years old. Have high metabolic symptoms, in line with laboratory diagnostic criteria for hyperthyroidism. No antiarrhythmic drugs, no history of chronic cough, high blood pressure, and other heart disease were taken. Methods: US DelMar263Holter analysis system, diagnosed with hyperthyroidism before treatment recorded Holter, after more than 3 months of regular treatment of the disease was stable after review. Results: ① 24-hour heart rate changes: the average 24-hour heart rate after treatment in this group decreased 18 times / min compared with before treatment. ② detection of arrhythmia: 1 case of persistent atrial fibrillation, 2 patients with paroxysmal atrial fibrillation turned to sinus rhythm after treatment, 13 cases of premature beats